{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T04:43:49Z","timestamp":1789879429318,"version":"4.0.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue des Maladies Respiratoires"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.rmr.2012.02.009","type":"journal-article","created":{"date-parts":[[2012,4,7]],"date-time":"2012-04-07T12:58:18Z","timestamp":1333803498000},"page":"537-544","source":"Crossref","is-referenced-by-count":4,"title":["BPCO\u00a0: une maladie associ\u00e9e \u00e0 une inflammation syst\u00e9mique"],"prefix":"10.1016","volume":"29","author":[{"given":"T.","family":"Rochat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmr.2012.02.009_bib0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0010","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/thx.2006.062802","article-title":"Developing COPD: a 25\u00a0year follow-up study of the general population","volume":"61","author":"Lokke","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1136\/thx.2005.053827","article-title":"Smoking related COPD and facial wrinkling: is there a common susceptibility?","volume":"61","author":"Patel","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1164\/rccm.200804-560OC","article-title":"Airflow limitation in smokers is associated with subclinical atherosclerosis","volume":"179","author":"Iwamoto","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0025","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/01.CIR.0000056767.69054.B3","article-title":"Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease","volume":"107","author":"Sin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.rmr.2012.02.009_bib0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/thx.2007.088112","article-title":"Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort","volume":"63","author":"Johnston","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0035","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1136\/thx.2004.037135","article-title":"Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis","volume":"60","author":"Wasswa-Kintu","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1164\/rccm.2108013","article-title":"Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease","volume":"166","author":"Agusti","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1164\/ajrccm.150.5.7952575","article-title":"Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease","volume":"150","author":"Di Francia","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0038-1648868","article-title":"Hypercoagulability state in patients with chronic obstructive pulmonary disease","volume":"72","author":"Alessandri","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rmr.2012.02.009_bib0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1136\/thx.2003.019588","article-title":"Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis","volume":"59","author":"Gan","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0060","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2350-10-23","article-title":"IL6\u00a0and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control study","volume":"10","author":"Yanbaeva","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.rmr.2012.02.009_bib0065","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1165\/rcmb.2009-0220TR","article-title":"The cytokine network in chronic obstructive pulmonary disease","volume":"41","author":"Barnes","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.rmr.2012.02.009_bib0070","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1164\/rccm.2202023","article-title":"Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum","volume":"166","author":"Vernooy","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0075","first-page":"387","article-title":"Translocation and cellular entering mechanisms of nanoparticles in the respiratory tract","volume":"138","author":"Muhlfeld","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.rmr.2012.02.009_bib0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199601183340303","article-title":"Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults","volume":"334","author":"Celermajer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0085","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1034\/j.1399-3003.2000.15e18.x","article-title":"The response of human bone marrow to chronic cigarette smoking","volume":"15","author":"van Eeden","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2012.02.009_bib0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1183\/09031936.04.00067904","article-title":"The immune response to resistive breathing","volume":"24","author":"Vassilakopoulos","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2012.02.009_bib0095","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1164\/rccm.200905-0722OC","article-title":"Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20\u00a0years\u2019 research","volume":"180","author":"Smolonska","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/thx.2010.147173","article-title":"The genetics of obstructive lung disease: big is beautiful","volume":"65","author":"Hall","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1183\/09031936.00088209","article-title":"Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study","volume":"35","author":"Eagan","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2012.02.009_bib0110","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/thx.2005.041996","article-title":"Raised CRP levels mark metabolic and functional impairment in advanced COPD","volume":"61","author":"Broekhuizen","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0115","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1183\/09031936.06.00109605","article-title":"C-reactive protein levels and clinically important predictive outcomes in stable COPD patients","volume":"27","author":"de Torres","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2012.02.009_bib0120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.200605-713OC","article-title":"C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease","volume":"175","author":"Dahl","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1164\/rccm.200810-1540OC","article-title":"C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease","volume":"179","author":"van Durme","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0130","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/thx.2005.042200","article-title":"C-reactive protein in patients with COPD, control smokers and non-smokers","volume":"61","author":"Pinto-Plata","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0135","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1183\/09031936.00162608","article-title":"Sex-specific effect of body weight gain on systemic inflammation in subjects with COPD: results from the SAPALDIA cohort study 2","volume":"34","author":"Bridevaux","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2012.02.009_bib0140","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.rmr.2012.02.009_bib0145","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1183\/09031936.00147805","article-title":"Genetic determinants of C-reactive protein in COPD","volume":"28","author":"Hersh","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmr.2012.02.009_bib0150","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1056\/NEJMoa063070","article-title":"Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease","volume":"356","author":"Calverley","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0155","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1164\/rccm.200404-543OC","article-title":"Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease","volume":"170","author":"Sin","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0160","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1164\/rccm.200709-1356OC","article-title":"The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease","volume":"177","author":"Sin","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0165","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease","volume":"182","author":"To","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0170","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/thx.2006.075937","article-title":"Reduction in sputum neutrophil and eosinophil numbers by the PDE4\u00a0inhibitor roflumilast in patients with COPD","volume":"62","author":"Grootendorst","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.rmr.2012.02.009_bib0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2006.00033.x","article-title":"C-reactive protein (CRP)-lowering agents","volume":"24","author":"Prasad","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.rmr.2012.02.009_bib0180","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cardfail.2006.02.001","article-title":"The effect of statins in heart failure: beyond its cholesterol-lowering effect","volume":"12","author":"Kurian","year":"2006","journal-title":"J Card Fail"},{"key":"10.1016\/j.rmr.2012.02.009_bib0185","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1164\/rccm.200501-041OC","article-title":"Simvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungs","volume":"172","author":"Lee","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0190","doi-asserted-by":"crossref","first-page":"L882","DOI":"10.1152\/ajplung.00238.2007","article-title":"Reversal of elastase-induced pulmonary emphysema and promotion of alveolar epithelial cell proliferation by simvastatin in mice","volume":"294","author":"Takahashi","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.rmr.2012.02.009_bib0195","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1164\/rccm.200705-656OC","article-title":"Statin use reduces decline in lung function: VA Normative Aging Study","volume":"176","author":"Alexeeff","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmr.2012.02.009_bib0200","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","article-title":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease","volume":"47","author":"Mancini","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.rmr.2012.02.009_bib0205","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1378\/chest.09-0194","article-title":"Statins in COPD: a systematic review","volume":"136","author":"Janda","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.rmr.2012.02.009_bib0210","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.amjcard.2007.09.102","article-title":"Usefulness of C-reactive protein and interleukin-6\u00a0as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin","volume":"101","author":"Lee","year":"2008","journal-title":"Am J Cardiol"}],"container-title":["Revue des Maladies Respiratoires"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842512000873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0761842512000873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T01:04:19Z","timestamp":1561597459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0761842512000873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0761842512000873"],"URL":"https:\/\/doi.org\/10.1016\/j.rmr.2012.02.009","relation":{},"ISSN":["0761-8425"],"issn-type":[{"value":"0761-8425","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}